Hospital-acquired infections

Surgery (United Kingdom)

Volumn 30, Issue 12, 2012, Pages 640-644

  Kelly, Kristin N ^a   Monson, John R T ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Clostridium difficile; healthcare associated infection; hospital acquired infection; meticillin resistant Staphylococcus aureus (MRSA); vancomycin resistant enterococci (VRE)

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; METRONIDAZOLE; NITROFURANTOIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DIARRHEA; HEALTH CARE COST; HEART VALVE PROSTHESIS; HOSPITAL INFECTION; HOSPITAL POLICY; HOSPITALIZATION; HUMAN; INFECTION RISK; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; OSTEOMYELITIS; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT INFECTION; RISK ASSESSMENT; RISK FACTOR; SKIN INFECTION; TREATMENT DURATION; URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84870513761     PISSN: 02639319     EISSN: 18781764     Source Type: Journal    
DOI: 10.1016/j.mpsur.2012.10.005     Document Type: Review

References (19)

1. G. Ducel, J. Fabry, and L. Nicolle Prevention of hospital-acquired infections. A practical guide 2002 World Health Organization Department of Communicable Disease, Surveillance, and Response 1-64
2. A.J. Kallen, Y. Mu, and S. Bulens Health care-associated invasive MRSA infections, 2005-2008 J Am Med Assoc 304 2011 641 648
3. M. van Rijen, M. Bonten, R. Wenzel, and J. Kluytmans Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers (Review) Cochrane Collaboration 2011
4. Health Protection Agency Quarterly epidemiological commentary: mandatory MRSA, MSSA and E. coli bacteraemia, and C. difficile infection data (up to October-December 2011) 2012 1-28. Available at: http://www.hpa.org.uk/webc/ HPAwebFile/HPAweb-C/1194947403482 [accessed 29.10.12]
5. E.A. Morell, and D.M. Balkin Methicillin-resistant staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development Yale J Biol Med 83 2010 223 233
6. B.S. Cooper, S.P. Stone, and C.C. Kibbler Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature Br Med J 329 2004 533 540
7. T. Lawes, B. Edwards, J.M. Lopez-Lozano, and I. Gould Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis BMJ Open 2 2012 e000797
8. R.L. Nelson, P. Kelsey, and H. Leeman Antibiotic treatment for Clostridium difficile-associated diarrhea in adults Cochrane Database Sys Rev 2011 Issue 9
9. T.S. Naimi, K.H. LeDell, and K. Como-Sabetti Comparison of community and health care associated methicillin-resistant Staphylococcus aureus infection J Am Med Assoc 290 2003 2976 2984
10. C. Liu, A. Bayer, and S.E. Cosgrove Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant staphylococcus aureus infections in adults and children Clin Infect Dis 52 2011 1 38
11. Health Protection Agency Clostridium difficile: findings and recommendations from a review of the epidemiology and a survey of directors of infection prevention and control in England 2006 1-56. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317133148297 [accessed 29.10.12]
12. M. Kachrimanidou, and N. Malislovas Clostridium difficile infection: a comprehensive review Crit Rev Microbiol 37 2011 178 187
13. V.G. Loo, A.M. Bourgault, and L. Poirier Host and pathogen factors for Clostridium difficile infection and colonization N Engl J Med 365 2011 1693 1703
14. E. Gough, H. Shaikh, and A.R. Manges Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection Clin Infect Dis 53 2011 994 1002
15. G. Werner, T.M. Coque, and A.M. Hammerum Emergence and spread of vancomycin resistance among enterococci in Europe Euro Surveill 13 2008 1 11
16. A. Zirakzadeh, and R. Patel Vancomycin-resistant enterococci: colonization, infection, detection, and treatment Mayo Clin Proc 81 2006 529 536
17. H.P. Loveday, C.M. Pellowe, S.R. Jones, and R.J. Pratt A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A) J Hosp Infect 63S 2006 S45 S70
18. Department of Health (UK) Hospital organisation, specialty mix and MRSA. Report no. 9163 2007 UK Government London
19. M.T. Hawn, C.C. Vick, and J. Richman Surgical site infection prevention time to move beyond the surgical care improvement program Ann Surg 254 2011 494 501